The recent management trend of global big perm is choice and concentration. The number of companies strengthening and separating specialized areas through mergers and spraying has increased significantly.

Sanofi Group, a French pharmaceutical company, was originally specialized in diabetes drugs such as insulin, but it absorbed Genzyme, a drug specializing in rare diseases, in 2011 and has been operating as an independent business unit so far. During the sale of OTC division last year, Opella Healthcare Corporation, which inherits some items as it is, was established and maintained as a group affiliate, and decided to maintain it as it was with Sanofipasteur, a vaccine corporation.

Change